Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, SpringWorks Therapeutics Inc increased its cash reserves by 159.54%, or 108.60m. Cash Flow from Financing totalled 296.64m or 5,445.92% of revenues. In addition the company used 222.80m for operations while cash from investing totalled 34.75m.
Cash flow per share | -4.33 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 7.50 |
---|---|
Tangible book value per share | 7.50 |
More ▼
Balance sheet in USDView more
Current ratio | 7.91 |
---|---|
Quick ratio | 7.77 |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼